AdaptHealth CAO granted 32,213 restricted stock units

AdaptHealth Corp.'s Chief Accounting Officer, Christine E. Archbold, reported an equity award in the form of restricted stock units.

Rhea-AI Filing Summary

AdaptHealth Corp.'s Chief Accounting Officer, Christine E. Archbold, reported an equity award in the form of restricted stock units. On January 30, 2026, she acquired 32,213 shares of common stock, represented by restricted stock units that will be settled in common stock upon vesting at a price of $0 per share. Following this grant, she beneficially owns 107,198 shares of AdaptHealth common stock, held directly.

Insider Trade Summary

Grant/Award: 32,213 shares

Grant/Award 1 txn

Insider Archbold Christine E.

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	32,213	$0.00	$0.00

Holdings After Transaction: Common Stock — 107,198 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Christine Archbold?

AdaptHealth reported that Chief Accounting Officer Christine E. Archbold acquired 32,213 shares of common stock on January 30, 2026. These shares are restricted stock units that will be settled in common stock upon vesting, increasing her direct beneficial ownership to 107,198 shares.

How many AdaptHealth (AHCO) shares does Christine Archbold own after this Form 4?

After the reported transaction, Christine E. Archbold beneficially owns 107,198 shares of AdaptHealth common stock. This total includes 32,213 shares represented by restricted stock units granted on January 30, 2026, which will convert into common stock when the units vest.

What type of equity did AdaptHealth grant to Christine Archbold in this filing?

The filing shows a grant of restricted stock units to Christine E. Archbold, representing 32,213 shares of AdaptHealth common stock. According to the footnote, these restricted stock units will be settled in shares of common stock when they vest, rather than being purchased for cash.

At what price were Christine Archbold’s AdaptHealth restricted stock units reported?

The 32,213 restricted stock units reported for Christine E. Archbold were acquired at a stated price of $0 per share. The Form 4 indicates this as an equity award rather than an open-market purchase, with settlement to occur in common stock upon vesting.

Is Christine Archbold a major shareholder or officer at AdaptHealth (AHCO)?

Christine E. Archbold is identified as an officer of AdaptHealth Corp. with the title Chief Accounting Officer. The Form 4 indicates she is not a director and not a 10% owner, but she holds 107,198 shares of common stock beneficially after the reported grant.

Does the Form 4 indicate whether Christine Archbold’s AdaptHealth shares are held directly?

Yes. The Form 4 shows Christine E. Archbold’s 107,198 AdaptHealth common shares as held with a direct ownership form. There is no indirect ownership or separate entity listed in the filing, and no footnote disclaiming voting or investment authority over these shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 08:15 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Archbold Christine E.

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		32,213(1)	A	$0	107,198	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Christine Archbold	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.